Use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers associated with lower risk of COVID-19 in household contacts.

<h4>Background</h4>Use of angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) has been hypothesized to affect COVID-19 risk.<h4>Objective</h4>To examine the association between use of ACEI/ARB and household transmission of COVID-19.<h4&g...

Full description

Bibliographic Details
Main Authors: Katrina Armstrong, Alex Soltoff, Meghan Rieu-Werden, Joshua Metlay, Jennifer Haas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0247548